$0.599
+0.0089 (+1.51%)
At Close: Jun 03, 2026
Study Results Demonstrated Favorable Safety Profile and Preliminary Signals of Clinical Activity REHOVOT, Israel, June 2, 2026 /PRNewswire/ -- Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), a p
EverGen Infrastructure Corp. (EVGN:CA) Q1 2026 Earnings Call Transcript
01:14pm, Friday, 29'th May 2026
EverGen Infrastructure Corp. (EVGN:CA) Q1 2026 Earnings Call Transcript
EverGen Infrastructure Reports Q1 2026 Results
05:57pm, Thursday, 28'th May 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), today reported financial results as at and for Q1 2026. All
Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript
02:00pm, Wednesday, 20'th May 2026
Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript
Evogene Reports First Quarter 2026 Financial Results
07:00am, Wednesday, 20'th May 2026
Conference call and webcast: today, May 20, 2026, 9:00 AM ET REHOVOT, Israel, May 20, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry�
Evogene to Present at the 24th Schrödinger European User Group Meeting
08:00am, Tuesday, 12'th May 2026
Conference will be held in Munich, Germany - May 19-21, 2026 REHOVOT, Israel, May 12, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry
Evogene Schedules First Quarter 2026 Financial Results Release
08:00am, Thursday, 07'th May 2026
Zoom conference call scheduled for May 20, 2026, 9:00 AM ET REHOVOT, Israel, May 7, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, spec
EverGen Infrastructure Corp. (EVGN:CA) Q4 2025 Earnings Call Transcript
04:41pm, Thursday, 30'th Apr 2026
EverGen Infrastructure Corp. (EVGN:CA) Q4 2025 Earnings Call Transcript
EverGen Infrastructure Reports Q4 & Year End 2025 Results
07:46pm, Wednesday, 29'th Apr 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), reported audited financial results as at and for Q4 2025 af
Evogene (NASDAQ:EVGN) Stock Crosses Below 200 Day Moving Average – Here’s Why
03:25am, Friday, 17'th Apr 2026
Evogene Ltd. (NASDAQ: EVGN - Get Free Report) shares crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $1.04 and traded as low as $0.78. Ev
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
04:01pm, Thursday, 02'nd Apr 2026
REHOVOT, Israel, April 2, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering company in computational chemistry, specializing in the generative desig
Today, castor oil is a premium sustainable industrial feedstock for bio-based products REHOVOT, Israel, March 31, 2026 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), a developer of high-yield castor s
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
09:00am, Monday, 09'th Mar 2026
Conference will be held at Lisbon, Portugal - March 23–25, 2026 REHOVOT, Israel, March 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemis
Evogene Q4 Earnings Call Highlights
04:48am, Saturday, 07'th Mar 2026
Evogene (NASDAQ: EVGN) executives used the company's fourth-quarter and full-year 2025 results call to outline a strategic transformation that narrowed its technology and market focus, while the finan
Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript
04:46pm, Thursday, 05'th Mar 2026
Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript
Sign In
Buy EVGN